the mean proportion of nonreactive alpha-fetoprotein was 13.4 % for patients with hepatocellular carcinoma , 62.2 % for testicular carcinoma , and 8.9 % for nonmalignant liver diseases .
C0002210
alpha-fetoprotein
C0023884
liver